Original Source(s)
Related Content
FDA Expands Bladder Cancer Regimen
KEYNOTE-B15/EV-304 demonstrated statistically significant improvements in event-free and overall survival with perioperative pembrolizumab plus enfortumab vedotin-ejfv compared with neoadjuvant gemcitabine plus cisplatin.
July 10, 2026
-
2 min
Routine Labs Linked to Stress-Related Disorder Risk
Higher hemoglobin and potassium levels, and lower low-density lipoprotein cholesterol levels, were associated with subsequent stress-related disorder risk in a Finnish cohort study of nearly 74,000 patients, although the findings were exploratory.
by Kerri Miller
July 13, 2026
-
5 min
Medical Oddities: When a Brush Beats a Scalpel
This research roundup has brain drama, bleeding control, skin science, and tiny brushes.
by Teraya Smith
July 7, 2026
-
5 min